Related Experiment Video
Updated: Jan 11, 2026

Monitoring of Systemic and Hepatic Hemodynamic Parameters in Mice
Published on: October 4, 2014
The Impact of Preoperative Hepatic Impairment on the Development of Postoperative Delirium: A Systematic Review and
Will S Roberts1, Vaibhav Mittal1, Michael N Ryan1
1Osteopathic Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Clearwater, USA.
Abstract:
Postoperative delirium (POD) is one of the most common psychiatric and neurologic complications experienced by patients undergoing general anesthesia. While it is widely hypothesized that hepatic impairment is associated with POD, the increased risk that various forms of preoperative hepatic impairment contribute to the development of POD is not well defined in the literature. A database search was performed on Embase, Web of Science, and MEDLINE-PubMed searching for articles containing keywords regarding the association between hepatic impairment and POD, ultimately yielding 34 studies for inclusion. Adjusted odds ratios (ORs) were extracted, with two-sided p-values <0.05 deemed significant. A total of 12,089 patients were included in this review, of which 2,663 developed POD (overall incidence of 22.03%). Inverse variance random-effects meta-analysis reveals that history of alcohol consumption (OR: 2.59, 1.85 - 3.64, p<0.0001), history of hepatic encephalopathy (OR: 3.42, 2.25 - 5.19, p<0.0001), and a MELD (Model for End-Stage Liver Disease) score ≥15 (OR 3.73, 1.93 - 7.20, p<0.0001) are independent risk factors for POD. Elevated serum IL-6 and total bilirubin did not reach significance as risk factors. Based on our findings, a medical history of known hepatic pathology potentially increases a patient's risk for POD. However, our study did not implicate any specific biomarkers as predisposing risk factors for POD but rather their indicated summative hepatic influence in the form of a MELD score.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Pharmacokinetics in Pediatric Patients: Drug Metabolism

